Company Filing History:
1 out of 64 
1 out of 6 Years Active: 2018
Title: Ilya Serebriiski: Innovator in Cancer Treatment
Introduction
Ilya Serebriiski is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer treatment. His innovative approach focuses on the treatment of MYC-amplified tumors, which are associated with various types of cancer. With a patent to his name, Serebriiski's work is paving the way for new therapeutic strategies.
Latest Patents
Serebriiski holds a patent for a method of treating MYC-amplified tumors with RNA-polymerase II inhibitors. This patent outlines systems and methods for determining whether a cancer patient may respond to inhibition of RNA polymerase II as a treatment. The inhibition may be achieved through chemotherapy using agents such as triptolide, its analogs, or prodrug forms. The patent specifically addresses treatment for patients with pancreatic, ovarian, gastric, or esophageal cancers, particularly those with over-expressed or over-amplified c-Myc.
Career Highlights
Throughout his career, Ilya Serebriiski has worked with esteemed organizations such as the Institute for Cancer Research and Nexuspharma, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Serebriiski has collaborated with notable colleagues, including Igor Astsaturov and Vladimir Khazak. These partnerships have contributed to the advancement of research and development in cancer therapies.
Conclusion
Ilya Serebriiski's work in the field of cancer treatment exemplifies the impact of innovation in medicine. His patented methods offer hope for patients with MYC-amplified tumors, showcasing the importance of research and collaboration in advancing healthcare solutions.